Peripheral and central mechanisms of fatigue in inflammatory and noninflammatory rheumatic diseases.
Staud, Roland · Current rheumatology reports · 2012 · DOI
Quick Summary
Fatigue in rheumatic diseases like ME/CFS, fibromyalgia, and lupus comes from both physical body problems and mental/central nervous system factors, not just one or the other. Doctors can measure physical fatigue through muscle tests and mental fatigue through questionnaires. Importantly, pain and mood problems are often stronger predictors of fatigue than the disease activity itself, and treatments for both medication and lifestyle changes can help.
Why It Matters
This study is important for ME/CFS patients and researchers because it provides a clinical framework for understanding fatigue as a multifactorial symptom involving both measurable peripheral mechanisms and central nervous system dysfunction. By emphasizing that psychological factors and pain are key drivers of fatigue independent of disease markers, it validates patient experiences and suggests that fatigue severity does not necessarily correlate with objective disease activity—a critical insight for personalized treatment approaches.
Observed Findings
Fatigue in rheumatic diseases involves both peripheral (muscle-based) and central (nervous system and psychological) mechanisms
Pain and negative affect are among the most powerful predictors of fatigue severity
Sleep problems and insomnia are less important predictors of fatigue than commonly assumed
Muscle function can be objectively measured through contractile force and action potential analysis
Multiple rheumatologic conditions (fibromyalgia, ME/CFS, rheumatoid arthritis, lupus, Sjögren's, ankylosing spondylitis) feature fatigue as a hallmark symptom
Inferred Conclusions
Fatigue should not be classified as purely central (psychological) or purely peripheral (physical), as most cases involve both mechanisms
Diseased-focused treatment strategies may be insufficient; addressing pain and negative affect may be essential for fatigue management
Both pharmacological and nonpharmacological interventions can be effective for treating fatigue in rheumatologic patients
Heterogeneous fatigue mechanisms across rheumatic diseases suggest the need for individualized assessment and treatment approaches
Remaining Questions
Which specific peripheral versus central mechanisms predominate in ME/CFS compared to other rheumatic diseases?
What This Study Does Not Prove
This narrative review does not establish causal mechanisms or provide new experimental evidence about fatigue pathophysiology in ME/CFS specifically. It does not prove which central or peripheral mechanisms are most important in individual patients, nor does it demonstrate that any single treatment strategy is universally effective across all rheumatic diseases. The review cannot determine whether fatigue causes pain and mood problems or vice versa.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →